Hemosiderosis: Difference between revisions
No edit summary |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infobox_Disease | |||
| Name = {{PAGENAME}} | |||
| Image = | |||
| Caption = | |||
| DiseasesDB = 29717 | |||
| ICD10 = | |||
| ICD9 = {{ICD9|516.1}} | |||
| ICDO = | |||
| OMIM = 178550 | |||
| MedlinePlus = | |||
| MeshID = | |||
}} | |||
{{Hemosiderosis}} | {{Hemosiderosis}} | ||
{{CMG}} | {{CMG}} [[Roghayeh Marandi]] | ||
{{SK}} Idiopathic | {{SK}} Idiopathic pulmonary hemosiderosis; IPH; hemosiderin accumulation; Pulmonary hemosiderosis; Pulmonary haemosiderosis; Essential brown induration of lung; Brown induration of lung; Ceelen-Gellerstedt syndrome | ||
==[[Hemosiderosis overview|Overview]]== | ==[[Hemosiderosis overview|Overview]]== | ||
==[[Hemosiderosis historical perspective|Historical Perspective]]== | ==[[Hemosiderosis historical perspective|Historical Perspective]]== | ||
==[[Hemosiderosis classification|Classification]]== | |||
==[[Hemosiderosis pathophysiology|Pathophysiology]]== | ==[[Hemosiderosis pathophysiology|Pathophysiology]]== | ||
==[[Hemosiderosis causes|Causes]]== | ==[[Hemosiderosis causes|Causes]]== | ||
| Line 17: | Line 32: | ||
==[[Hemosiderosis risk factors|Risk Factors]]== | ==[[Hemosiderosis risk factors|Risk Factors]]== | ||
==[[Hemosiderosis screening|Screening]]== | |||
==[[Hemosiderosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Hemosiderosis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
Latest revision as of 08:15, 28 September 2020
| Hemosiderosis | |
| ICD-9 | 516.1 |
|---|---|
| OMIM | 178550 |
| DiseasesDB | 29717 |
|
Hemosiderosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemosiderosis On the Web |
|
American Roentgen Ray Society Images of Hemosiderosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Roghayeh Marandi
Synonyms and keywords: Idiopathic pulmonary hemosiderosis; IPH; hemosiderin accumulation; Pulmonary hemosiderosis; Pulmonary haemosiderosis; Essential brown induration of lung; Brown induration of lung; Ceelen-Gellerstedt syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemosiderosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies